Bleeding diathesis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 71: | Line 71: | ||
|- | |- | ||
| rowspan="12" |Coagulation disorders | | rowspan="12" |Coagulation disorders | ||
|Fibrinogen | |Fibrinogen deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
|Prothrombin | |Prothrombin deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor V | | rowspan="1" |Factor V deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor VII | | rowspan="1" |Factor VII deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor VIII | | rowspan="1" |Factor VIII deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor IX | | rowspan="1" |Factor IX deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor X | | rowspan="1" |Factor X deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor XI | | rowspan="1" |Factor XI deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor XII | | rowspan="1" |Factor XII deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
|HK | |HK deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Prekallikrein | | rowspan="1" |Prekallikrein deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor XIII | | rowspan="1" |Factor XIII deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
| rowspan="3" |[[Hemophilia]] | | rowspan="3" |[[Hemophilia]] | ||
|Type A | |Type A deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
|Type B | |Type B deficiency | ||
| | | | ||
| | | | ||
|- | |- | ||
|Type C | |Type C deficiency | ||
| | | | ||
| | | |
Revision as of 17:43, 6 August 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2]
Overview
Classification
Differential Diagnosis
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia | |
Drug-Induced Thrombocytopenia | |||
Heparin-Induced Thrombocytopenia | |||
Immune Thrombocytopenic Purpura (ITP) | |||
Inherited Thrombocytopenia | |||
Thrombotic Thrombocytopenic Purpura (TTP) | |||
Hemolytic Uremic Syndrome | |||
Thromobcytosis | Thrombocytosis in response to acute or chronic inflammation has not been associated with an increased thrombotic risk. In fact, patients with markedly elevated platelet counts (>1.5 million), usually seen in the setting of a myeloproliferative disorder, have an increased risk of bleeding. This appears to be due, at least in part, to acquired von Willebrand disease (VWD) due to platelet-VWF adhesion and removal. | ||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | ||
Acquired Disorders of Platelet Function | |||
von Willebrand Disease | Type 1 | ||
Type 2 A | |||
Type 2 B | |||
Type 2 M | |||
Type 3 | |||
Vessel wall disorders | Metabolic and Inflammatory Disorders | ||
Inherited Disorders of the Vessel Wall | |||
Coagulation disorders | Fibrinogen deficiency | ||
Prothrombin deficiency | |||
Factor V deficiency | |||
Factor VII deficiency | |||
Factor VIII deficiency | |||
Factor IX deficiency | |||
Factor X deficiency | |||
Factor XI deficiency | |||
Factor XII deficiency | |||
HK deficiency | |||
Prekallikrein deficiency | |||
Factor XIII deficiency | |||
Hemophilia | Type A deficiency | ||
Type B deficiency | |||
Type C deficiency | |||
Rare diseases | Disseminated Intravascular Coagulation | ||
Vitamin K Deficiency | |||
Coagulation Disorders Associated with Liver Failure | |||
Acquired Inhibitors of Coagulation Factors |